Patents involving antibody medicines (antibody patents) are largely grouped into patents specified by antibody amino acid sequences (antibody sequence-based patents) and those not (non-sequence-based patents). Non-sequence-based patents have a broad scope and are thus very useful for protecting antibody medicines. Here, I investigate a recent trend in antibody patents characterized by an antibody-binding site in an antigen.
Patent
- Enablement
- Fee Shifting
- Litigation
- CAFC Nixes District Court Claim Construction in Win for Firearms Patent Owner
- Tips for Litigating Multiple Simultaneous Patent Infringement Investigations at the ITC
- Other Barks & Bites for Friday, January 14: Property Rights Groups Oppose SEP Draft Policy Statement, PTAB POP Issues Ruling on Wire Transfer of IPR Filing Fee, and SCOTUS Denies Appeal in Breach of Royalty Agreement Case
- Senate Judiciary Committee Sends Vidal and Stark Nominations to Senate Floor
- SCOTUS, Vaccine Mandates and Patent Law: God Help Us
Recent Posts
- CAFC Nixes District Court Claim Construction in Win for Firearms Patent Owner
- Tips for Litigating Multiple Simultaneous Patent Infringement Investigations at the ITC
- Other Barks & Bites for Friday, January 14: Property Rights Groups Oppose SEP Draft Policy Statement, PTAB POP Issues Ruling on Wire Transfer of IPR Filing Fee, and SCOTUS Denies Appeal in Breach of Royalty Agreement Case
- Senate Judiciary Committee Sends Vidal and Stark Nominations to Senate Floor
- SCOTUS, Vaccine Mandates and Patent Law: God Help Us